Moderna

US regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week.

The government is offering a booster dose against COVID to kids from the age of 12 to 17.

Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6.

Even though it’s not clear if changes are needed.

Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant.

U.S. health officials are beginning to grapple with how to keep the vaccines updated.

The 'Moderna' vaccine against Covid-19's distribution has begun for students

US Centers for Disease Control and Prevention continued its endorsement of Moderna’s COVID-19 vaccine for adults.

Moderna's COVID-19 vaccine 'Spikevax' received full approval from the U.S. Food and Drug Administration (FDA), after more than a year of its "emergency use authorization", reported USA TODAY.